Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New elbow replacement surgery to be trialled
“The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising” – Andy Moores.
Two referral clinics given RCVS approval to carry out procedure.

The Royal College of Veterinary Surgeons (RCVS) Ethics Review Panel has given approval for a new elbow replacement surgery for dogs to be trialled at two referral clinics.

The third-generation Biomedtrix TATE elbow replacement surgery is the latest design of the TATE elbow replacement that first came into clinical use in the 2010s.

The new implant has already been in use in a small number of US practices. It includes new instrumentation designed to maximise the accuracy of bone preparation for the implants and a new implant design that is said to offer improved stability.

One of the clinics where it will be trialled is Moores Orthopaedic Clinic in Upton Grey, Hampshire. Andy Moores, clinical director and head of the joint replacement programme at the clinic, recently became certified to perform the third-generation TATE elbow replacement surgery after attending the first TATE technology course in Boston, USA.

The surgery is also available at Wear Referrals in Bradbury, County Durham, as part of the clinical evaluation trial. The practice is currently seeing cases for preliminary assessment for the surgery.

The procedure will be available for suitable patients with severe elbow osteoarthritis. The outcomes of the surgeries will be closely monitored and documented.

Dr Moores said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.

“The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.

“We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this. We look forward to offering this surgery as an option for some of our most painful canine patients.”

Image © Moores Orthopaedic Clinic

Become a member or log in to add this story to your CPD history

Prof Joanne Webster elected as Fellow of the Royal Society

News Story 1
 Joanne Webster, a professor of parasitic diseases at the RVC, has been elected as a Fellow of the Royal Society (FRS).

An infectious disease expert, Prof Webster is known for promoting a One Health approach to disease control.

She completed her doctoral research in zoonotic disease and parasite-host interactions, and has since earned widespread recognition for contributions to parasitology and global health.

Prof Webster said: "I am truly honoured, and somewhat stunned, to be recognised alongside such an exceptional group of scientists." 

Click here for more...
News Shorts
Germany FMD import restrictions eased

The UK government has lifted the import restrictions placed on FMD-susceptible commodities from Germany.

The decision comes after the country was recognised as foot-and-mouth disease free without vaccination on 14 May.

Imports of FMD-susceptible animals and their by-products from Germany were originally banned, after the country reported a case of FMD near Brandenburg in January. In March, the UK government permitted imports from outside of the outbreak zone.

Germany will now be able to import FMD-susceptible animals and their by-products into the UK, providing they meet other import conditions.

The decision follows rigorous technical assessment of measures in Germany. Defra says it will not hesitate respond to FMD outbreaks.